BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15702923)

  • 1. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MD simulations of anthrax edema factor: calmodulin complexes with mutations in the edema factor "switch a" region and docking of 3'-deoxy ATP into the adenylyl cyclase active site of wild-type and mutant edema factor variants.
    Zhao J; Roy SA; Nelson DJ
    J Biomol Struct Dyn; 2003 Oct; 21(2):159-70. PubMed ID: 12956602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
    Wu G; Feng C; Cao S; Guo A; Liu Z
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S; Miyagi M; Bann JG
    Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax toxin: the long and winding road that leads to the kill.
    Abrami L; Reig N; van der Goot FG
    Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Blachinsky E; Kobiler D
    Microb Pathog; 2011 Nov; 51(5):345-51. PubMed ID: 21791242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
    Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble expression and purification of the anthrax protective antigen in E. coli and identification of a novel dominant-negative mutant N435C.
    Wu G; Feng C; Hong Y; Guo A; Cao S; Dong J; Lin L; Liu Z
    Appl Microbiol Biotechnol; 2010 Jun; 87(2):609-16. PubMed ID: 20213183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
    Varughese M; Teixeira AV; Liu S; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the cellular receptor for anthrax toxin.
    Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
    Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anthrax toxins].
    Brossier F; Guidi-Rontani C; Mock M
    C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.